Dorzolamide 20 MG/ML Ophthalmic Solution — RxCUI 310015
RxNorm drug concept · Semantic clinical drug
RxCUI 310015
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310015
Official nameDorzolamide 20 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdorzolamide 2 % Ophthalmic Solution; dorzolamide HCl 2 % Ophthalmic Solution; dorzolamide 20 MG/ML (as dorzolamide HCl 22.3 MG/ML) Ophthalmic Solution
FDA products mapped15
Package NDCs mapped16
Reported Medicaid activity (SDUD)67,286 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dorzolamide Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Your eye constantly makes a fluid that keeps it properly pressurized — but in some people, that pressure gets too high, which can damage the optic nerve over time. Dorzolamide bloc...
- What exactly does dorzolamide do for my eyes?
- Yes, that's very common with dorzolamide — about one in four people notice it. Eye drops can drain into the back of your throat through a small channel between your eye and nose, w...
- I always get a bitter taste after using my eye drops — is that normal?
🕸️ Concept Web — How Dorzolamide 20 MG/ML Ophthalmic Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dorzolamide 20 MG/ML Ophthalmic Solution
RxCUI 310015 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dorzolamide
60207IN
-
Dorzolamide
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dorzolamide Ophthalmic Solution
377440SCDF -
Dorzolamide Ophthalmic Product
1160644SCDG -
Ophthalmic Solution
7670DF -
Ophthalmic Product
1151135DFG
-
Dorzolamide Ophthalmic Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dorzolamide 20 MG/ML
328229SCDC
-
Dorzolamide 20 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dorzolamide 20 MG/ML
SCDC · 328229 -
Dorzolamide Ophthalmic Solution
SCDF · 377440 -
Dorzolamide Ophthalmic Product
SCDG · 1160644
📦 FDA Products & Package NDCs
15 products · 16 package NDCs
16 package NDCs map to RxCUI 310015 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 14445-0404-10 | 1 BOTTLE, DISPENSING in 1 CARTON (14445-404-10) / 10 mL in... | Dorzolamide Hydrochloride | Indoco Remedies Limited | 2021-05-14 |
| 24208-0485-10 | 1 BOTTLE, DROPPER in 1 CARTON (24208-485-10) / 10 mL in 1 B... | Dorzolamide HCl | Bausch & Lomb Incorporated | 2009-06-25 |
| 25021-0006-10 | 1 BOTTLE in 1 CARTON (25021-006-10) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride | Sagent Pharmaceuticals | 2026-01-15 |
| 42571-0141-26 | 1 BOTTLE in 1 CARTON (42571-141-26) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride Ophthalmic Solution | Micro Labs Limited | 2019-11-11 |
| 46708-0519-10 | 1 BOTTLE in 1 CARTON (46708-519-10) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride | Alembic Pharmaceuticals Limited | 2019-08-09 |
| 50090-2406-00 | 1 BOTTLE, DROPPER in 1 CARTON (50090-2406-0) / 10 mL in 1 B... | Dorzolamide HCl | A-S Medication Solutions | 2016-05-18 |
| 50090-4882-00 | 1 BOTTLE in 1 CARTON (50090-4882-0) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride Ophthalmic | A-S Medication Solutions | 2020-02-11 |
| 61314-0019-10 | 10 mL in 1 BOTTLE (61314-019-10) | DORZOLAMIDE HYDROCHLORIDE | Sandoz Inc | 2009-06-01 |
| 62332-0519-10 | 1 BOTTLE in 1 CARTON (62332-519-10) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride | Alembic Pharmaceuticals Inc. | 2019-08-09 |
| 68083-0489-01 | 1 BOTTLE in 1 CARTON (68083-489-01) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride | Gland Pharma Limited | 2022-01-27 |
| 69315-0304-05 | 1 BOTTLE in 1 CARTON (69315-304-05) / 5 mL in 1 BOTTLE | Dorzolamide hydrochloride | Leading Pharma, LLC | 2019-12-01 |
| 69315-0304-10 | 1 BOTTLE in 1 CARTON (69315-304-10) / 10 mL in 1 BOTTLE | Dorzolamide hydrochloride | Leading Pharma, LLC | 2019-12-01 |
| 70069-0501-01 | 1 BOTTLE in 1 CARTON (70069-501-01) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride | Somerset Therapeutics, LLC | 2025-02-12 |
| 71921-0400-10 | 10 mL in 1 BOTTLE (71921-400-10) | Dorzolamide Hydrochloride Ophthalmic | Florida Pharmaceutical Products, LLC | 2025-05-07 |
| 72266-0197-01 | 1 BOTTLE in 1 CARTON (72266-197-01) / 10 mL in 1 BOTTLE | Dorzolamide Hydrochloride | FOSUN PHARMA USA INC | 2023-01-23 |
| 72888-0077-15 | 1 BOTTLE in 1 CARTON (72888-077-15) / 10 mL in 1 BOTTLE | DORZOLAMIDE HYDROCHLORIDE | Advagen Pharma Ltd. | 2024-12-23 |
Observed labelers:
A-S Medication Solutions (2) ·
Leading Pharma, LLC (2) ·
Advagen Pharma Ltd. (1) ·
Alembic Pharmaceuticals Inc. (1) ·
Alembic Pharmaceuticals Limited (1) ·
Bausch & Lomb Incorporated (1)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.